Department of Psychology, Indiana University-Purdue University Indianapolis.
Department of Applied Health Science, Indiana University, Bloomington.
Am Psychol. 2020 Sep;75(6):784-795. doi: 10.1037/amp0000636.
In response to the dual public health crises of chronic pain and opioid use, providers have become more vigilant about assessing patients for risk of opioid-related problems. Little is known about how providers are making these risk assessments. Given previous studies indicating that Black patients are at increased risk for suboptimal pain care, which may be related to stereotypes about drug abuse, the current study examined how patient race and previous opioid misuse behaviors impact providers' risk assessments for future prescription opioid-related problems. Physician residents and fellows (N = 135) viewed videos and read vignettes about 8 virtual patients with chronic pain who varied by race (Black/White) and history of prescription opioid misuse (absent/present). Providers rated patients' risk for future prescription opioid-related adverse events, misuse/abuse, addiction, and diversion, and also completed measures of implicit racial attitudes and explicit beliefs about race differences in pain. Two significant interactions emerged indicating that Black patients were perceived to be at greater risk for future adverse events (when previous misuse was absent) and diversion (when previous misuse was present). Significant main effects indicated that Black patients and patients with previous misuse were perceived to be at greater risk for future misuse/abuse of prescription opioids, and that patients with previous misuse were perceived to be at greater risk of addiction. These findings suggest that racial minorities and patients with a history of prescription opioid misuse are particularly vulnerable to any unintended consequences of efforts to stem the dual public health crises of chronic pain and opioid use. (PsycInfo Database Record (c) 2020 APA, all rights reserved).
针对慢性疼痛和阿片类药物使用这双重公共卫生危机,医务人员在评估患者阿片类药物相关问题风险方面变得更加警惕。关于医务人员如何进行这些风险评估,我们知之甚少。鉴于先前的研究表明,黑人患者接受不佳的疼痛治疗的风险增加,这可能与关于药物滥用的刻板印象有关,因此当前的研究检查了患者的种族和以前的阿片类药物滥用行为如何影响提供者对未来处方类阿片类药物相关问题的风险评估。医生住院医师和研究员(N = 135)观看了有关 8 名患有慢性疼痛的虚拟患者的视频和案例介绍,这些患者的种族(黑人/白人)和处方类阿片类药物滥用史(无/有)各不相同。医务人员对患者未来处方类阿片类药物相关不良事件、滥用/误用、成瘾和转移的风险进行了评分,并完成了对隐性种族态度和对疼痛方面种族差异的显性信念的测量。有两个重要的交互作用表明,当以前没有滥用时,黑人患者被认为未来发生不良事件的风险更高(当以前没有滥用时),而当以前有滥用时,黑人患者被认为未来转移的风险更高。显著的主要效应表明,黑人患者和以前有过滥用史的患者被认为未来滥用处方类阿片类药物的风险更高,而以前有过滥用史的患者被认为成瘾的风险更高。这些发现表明,少数族裔和有处方类阿片类药物滥用史的患者特别容易受到遏制慢性疼痛和阿片类药物使用双重公共卫生危机的努力的任何意外后果的影响。(PsycInfo 数据库记录(c)2020 APA,保留所有权利)。